XML 16 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Revenue from Grants $ 93,130 $ 223,089 $ 322,086 $ 180,441 $ 157,340 $ 174,738 $ 1,004,211 $ 441,561 $ 797,040 $ 268,028 $ 659,867 $ 882,956 $ 2,417,550 $ 2,657,327
Operating expenses:                            
Research and development 378,521   425,498             1,166,803 1,344,560 1,812,969 2,914,878 3,043,522
General and Administrative Expense 335,932   411,814             1,102,262 1,128,478 1,807,605 1,792,160 1,752,765
Total operating expenses 714,453   837,312             2,269,065 2,473,038 3,620,574 4,707,038 4,796,287
Loss from operations (621,323)   (515,226)             (2,001,037) (1,813,171) (2,737,618) (2,289,488) (2,138,960)
Other income:                            
Interest income 1,424   711             4,481 3,201 4,063 4,545 3,820
Total other income 1,424   711             4,481 3,201 4,063 4,545 3,820
Net loss $ (619,899) $ (923,585) $ (514,515) $ (679,537) $ (615,918) $ (871,714) $ (190,148) $ (526,284) $ (696,797) $ (1,996,556) $ (1,809,970) $ (2,733,555) $ (2,284,943) $ (2,135,140)
Basic and diluted:                            
Loss per common share (in dollars per share) $ (0.02)   $ (0.02)             $ (0.06) $ (0.07) $ (0.10) $ (0.11) $ (0.12)
Weighted averages shares outstanding (in shares) 31,950,813   25,325,141             31,950,813 25,109,811 26,645,140 21,212,327 18,315,669